Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease

Neuropharmacology

Volumn 81, Issue , 2014, Pages 311-317

  Do, Tuan Minh ^a   Alata, Wael ^b   Dodacki, Agnès ^c,d   Traversy, Marie Thérèse ^b   Chacun, Hélène ^e   Pradier, Laurent ^f   Scherrmann, Jean Michel ^c,d   Farinotti, Robert ^a   Calon, Frédéric ^b   Bourasset, Fanchon ^c,d  

^a EA4123   (France)

^b UNIVERSITÉ LAVAL   (Canada)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e UNIV PARIS SUD   (France)

^f SANOFI   (France)

Author keywords

3xTg AD; Alzheimer's disease; APP PS1; Blood brain barrier integrity; Brain vascular volume; In situ brain perfusion

Indexed keywords

AMYLOID PRECURSOR PROTEIN; AMYLOID PROTEIN; DIAZEPAM; GLUCOSE; GLUCOSE TRANSPORTER 1; PRESENILIN 1; TAU PROTEIN; TRITIUM; PSEN1 PROTEIN, HUMAN; SLC2A1 PROTEIN, MOUSE; SUCROSE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VOLUME; BRAIN DAMAGE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIFFUSION; GLUCOSE TRANSPORT; MEMBRANE TRANSPORT; MOUSE; MOUSE MODEL; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SENILE PLAQUE; TRANSGENIC MOUSE; AGE; ANIMAL; BRAIN; BRAIN CIRCULATION; DISEASE MODEL; DRUG EFFECTS; GENETICS; HEMISPHERIC DOMINANCE; HUMAN; METABOLISM; MICROVASCULATURE; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CEREBROVASCULAR CIRCULATION; DIAZEPAM; DISEASE MODELS, ANIMAL; FUNCTIONAL LATERALITY; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MICE; MICE, TRANSGENIC; MICROVESSELS; MUTATION; PRESENILIN-1; SUCROSE; TAU PROTEINS;

EID: 84897829598     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.02.010     Document Type: Article

References (53)

1. W. Alata, S. Paris-Robidas, V. Emond, F. Bourasset, and F. Calon Brain uptake of a fluorescent vector targeting the transferrin receptor: a novel application of in situ brain perfusion Mol. Pharm. 11 2014 243 253
2. R.D. Bell, and B.V. Zlokovic Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease Acta Neuropathol. 118 2009 103 113
3. F. Bourasset, O. Melissa, C. Tremblay, C. Julien, T.M. Do, S. Oddo, F. LaFerla, and F. Calon Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease Neuropharmacology 56 2009 808 813
4. G.L. Bowman, J.A. Kaye, M. Moore, D. Waichunas, N.E. Carlson, and J.F. Quinn Blood-brain barrier impairment in Alzheimer disease: stability and functional significance Neurology 68 2007 1809 1814
5. M.M. Breteler Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study Ann. N. Y. Acad. Sci. 903 2000 457 465
6. L. Bronge Magnetic resonance imaging in dementia. A study of brain white matter changes Acta Radiol. Suppl. 2002 1 32
7. 2 in Alzheimer's disease using BOLD fMRI Neuroimage 58 2011 579 587
8. D. Carnevale, G. Mascio, I. D'Andrea, V. Fardella, R.D. Bell, I. Branchi, F. Pallante, B. Zlokovic, S.S. Yan, and G. Lembo Hypertension induces brain beta-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature Hypertension 60 2012 188 197
9. C. Choeiri, W. Staines, and C. Messier Immunohistochemical localization and quantification of glucose transporters in the mouse brain Neuroscience 111 2002 19 34
10. C. Dagenais, C. Rousselle, G.M. Pollack, and J.M. Scherrmann Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice J. Cereb. Blood Flow Metab. 20 2000 381 386
11. J.C. de la Torre Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics Lancet Neurol. 3 2004 184 190
12. F. Ding, J. Yao, J.R. Rettberg, S. Chen, and R.D. Brinton Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention PLoS One 8 2013 e79977
13. T.M. Do, B. Bedussi, S. Chasseigneaux, A. Dodacki, C. Yapo, H. Chacun, J.M. Scherrmann, R. Farinotti, and F. Bourasset Oatp1a4 and a L-thyroxine-sensitive transporter mediate the mouse blood-brain barrier transport of amyloid-beta peptide J. Alzheimers Dis. 36 2013 555 561
14. T.M. Do, M.S. Noel-Hudson, S. Ribes, C. Besengez, M. Smirnova, S. Cisternino, M. Buyse, F. Calon, G. Chimini, H. Chacun, J.M. Scherrmann, R. Farinotti, and F. Bourasset ABCG2 and ABCG4-mediated efflux of amyloid-beta peptide 1-40 at the mouse blood-brain barrier J. Alzheimers Dis. 30 2012 155 166
15. A. Dorr, B. Sahota, L.V. Chinta, M.E. Brown, A.Y. Lai, K. Ma, C.A. Hawkes, J. McLaurin, and B. Stefanovic Amyloid-beta-dependent compromise of microvascular structure and function in a model of Alzheimer's disease Brain 135 2012 3039 3050
16. T. El Tayara Nel, B. Delatour, A. Volk, and M. Dhenain Detection of vascular alterations by in vivo magnetic resonance angiography and histology in APP/PS1 mouse model of Alzheimer's disease MAGMA 23 2010 53 64
17. M.A. Gama Sosa, R.D. Gasperi, A.B. Rocher, A.C. Wang, W.G. Janssen, T. Flores, G.M. Perez, J. Schmeidler, D.L. Dickstein, P.R. Hof, and G.A. Elder Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations Am. J. Pathol. 176 2010 353 368
18. L. Glodzik, H. Rusinek, M. Brys, W.H. Tsui, R. Switalski, L. Mosconi, R. Mistur, E. Pirraglia, S. de Santi, Y. Li, A. Goldowsky, and M.J. de Leon Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia J. Cereb. Blood Flow Metab. 31 2011 671 679
19. C.X. Gong, F. Liu, I. Grundke-Iqbal, and K. Iqbal Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation J. Alzheimers Dis. 9 2006 1 12
20. F. Gosselet, P. Candela, R. Cecchelli, and L. Fenart Role of the blood-brain barrier in Alzheimer's disease Med. Sci. (Paris) 27 2011 987 992
21. B.T. Hawkins, and R.D. Egleton Pathophysiology of the blood-brain barrier: animal models and methods Curr. Top. Dev. Biol. 80 2008 277 309
22. B.P. Head, J.N. Peart, M. Panneerselvam, T. Yokoyama, M.L. Pearn, I.R. Niesman, J.A. Bonds, J.M. Schilling, A. Miyanohara, J. Headrick, S.S. Ali, D.M. Roth, P.M. Patel, and H.H. Patel Loss of caveolin-1 accelerates neurodegeneration and aging PLoS One 5 2010 e15697
23. C.R. Hooijmans, C. Graven, P.J. Dederen, H. Tanila, T. van Groen, and A.J. Kiliaan Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice Brain Res. 1181 2007 93 103
24. S. Hoyer Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications Adv. Exp. Med. Biol. 541 2004 135 152
25. J.M. Hunter, J. Kwan, M. Malek-Ahmadi, C.L. Maarouf, T.A. Kokjohn, C. Belden, M.N. Sabbagh, T.G. Beach, and A.E. Roher Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease PLoS One 7 2012 e36893
26. T. Jaworski, B. Lechat, D. Demedts, L. Gielis, H. Devijver, P. Borghgraef, H. Duimel, F. Verheyen, S. Kugler, and F. Van Leuven Dendritic degeneration, neurovascular defects, and inflammation precede neuronal loss in a mouse model for tau-mediated neurodegeneration Am. J. Pathol. 179 2011 2001 2015
27. C. Julien, C. Tremblay, A. Phivilay, L. Berthiaume, V. Emond, P. Julien, and F. Calon High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model Neurobiol. Aging 31 2010 1516 1531
28. R.N. Kalaria Small vessel disease and Alzheimer's dementia: pathological considerations Cerebrovasc. Dis. 13 Suppl. 2 2002 48 52
29. R.N. Kalaria, and S.I. Harik Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease J. Neurochem. 53 1989 1083 1088
30. H. Kitaguchi, M. Ihara, H. Saiki, R. Takahashi, and H. Tomimoto Capillary beds are decreased in Alzheimer's disease, but not in Binswanger's disease Neurosci. Lett. 417 2007 128 131
31. A. Kovac, M. Zilkova, M.A. Deli, N. Zilka, and M. Novak Human truncated tau is using a different mechanism from amyloid-beta to damage the blood-brain barrier J. Alzheimers Dis. 18 2009 897 906
32. G.D. Lee, J.H. Aruna, P.M. Barrett, D.L. Lei, D.K. Ingram, and P.R. Mouton Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease Brain Res. Bull. 65 2005 317 322
33. Y. Liu, F. Liu, K. Iqbal, I. Grundke-Iqbal, and C.X. Gong Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease FEBS Lett. 582 2008 359 364
34. F. Luo, N.R. Rustay, U. Ebert, V.P. Hradil, T.B. Cole, D.A. Llano, S.R. Mudd, Y. Zhang, G.B. Fox, and M. Day Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease Neurobiol. Aging 33 2010 933 944
35. K.G. Mawuenyega, W. Sigurdson, V. Ovod, L. Munsell, T. Kasten, J.C. Morris, K.E. Yarasheski, and R.J. Bateman Decreased clearance of CNS beta-amyloid in Alzheimer's disease Science 330 2010 1774
36. M. Merlini, E.P. Meyer, A. Ulmann-Schuler, and R.M. Nitsch Vascular beta-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAbeta mice Acta Neuropathol. 122 2011 293 311
37. E. Nagababu, P.V. Usatyuk, D. Enika, V. Natarajan, and J.M. Rifkind Vascular endothelial barrier dysfunction mediated by amyloid-beta proteins J. Alzheimers Dis. 17 2009 845 854
38. N. Nicolakakis, T. Aboulkassim, A. Aliaga, X.K. Tong, P. Rosa-Neto, and E. Hamel Intact memory in TGF-beta1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone J. Cereb. Blood Flow Metab. 31 2011 200 211
39. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, R. Kayed, R. Metherate, M.P. Mattson, Y. Akbari, and F.M. LaFerla Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction Neuron 39 2003 409 421
40. B. Ongali, N. Nicolakakis, C. Lecrux, T. Aboulkassim, P. Rosa-Neto, P. Papadopoulos, X.K. Tong, and E. Hamel Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer's disease Am. J. Pathol. 177 2010 3071 3080
41. J.F. Poduslo, G.L. Curran, T.M. Wengenack, B. Malester, and K. Duff Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease Neurobiol. Dis. 8 2001 555 567
42. A.A. Qutub, and C.A. Hunt Glucose transport to the brain: a systems model Brain Res. Brain Res. Rev. 49 2005 595 617
43. T. Rabie, R. Kunze, and H.H. Marti Impaired hypoxic response in senescent mouse brain Int. J. Dev. Neurosci. 29 2011 655 661
44. A. Rancillac, H. Geoffroy, and J. Rossier Impaired neurovascular coupling in the APPxPS1 mouse model of Alzheimer's disease Curr. Alzheimer Res. 9 2012 1221 1230
45. E. Richard, W.A. van Gool, J.J. Hoozemans, E.S. van Haastert, P. Eikelenboom, A.J. Rozemuller, and W.D. van de Berg Morphometric changes in the cortical microvascular network in Alzheimer's disease J. Alzheimers Dis. 22 2010 811 818
46. T. Sasaki, M. Senda, S. Kim, S. Kojima, and A. Kubodera Age-related changes of glutathione content, glucose transport and metabolism, and mitochondrial electron transfer function in mouse brain Nucl. Med. Biol. 28 2001 25 31
47. I.A. Simpson, K.R. Chundu, T. Davies-Hill, W.G. Honer, and P. Davies Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease Ann. Neurol. 35 1994 546 551
48. J.M. Starr, A.J. Farrall, P. Armitage, B. McGurn, and J. Wardlaw Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study Psychiatry Res. 171 2009 232 241
49. M. Ujiie, D.L. Dickstein, D.A. Carlow, and W.A. Jefferies Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model Microcirculation 10 2003 463 470
50. J. Valla, F. Gonzalez-Lima, and E.M. Reiman FDG autoradiography reveals developmental and pathological effects of mutant amyloid in PDAPP transgenic mice Int. J. Dev. Neurosci. 26 2008 253 258
51. L.O. Wahlund, and L. Bronge Contrast-enhanced MRI of white matter lesions in patients with blood-brain barrier dysfunction Ann. N. Y. Acad. Sci. 903 2000 477 481
52. V. Zerbi, D. Jansen, P.J. Dederen, A. Veltien, B. Hamans, Y. Liu, A. Heerschap, and A.J. Kiliaan Microvascular cerebral blood volume changes in aging APP(swe)/PS1 (dE9) AD mouse model: a voxel-wise approach Brain Struct. Funct. 218 2012 1085 1098
53. B.V. Zlokovic Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders Nat. Rev. Neurosci. 12 2011 723 738